Latest news and articles about pharmacovigilance
Total: 1 articles found
China will bar registration renewals for patent Chinese medicines that still list safety information as “unclear” after July 1, 2026. Roughly 40,000 of 57,000 licensed products currently carry such wording and must revise labels or face delisting, a move framed as patient‑safety enforcement but contested by some practitioners and consumers.
